High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk

(2018) Suzan Vreemann et al.   RADIOLOGY

Hereditary Breast and Ovarian Cancer

(2018) Alfons Meindl et al.   Deutsches Arzteblatt International

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis

(2017) Xuan-Anh Phi et al.   EUROPEAN JOURNAL OF CANCER

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B. Kuchenbaecker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

(2016) Dana Madorsky-Feldman et al.   BREAST CANCER RESEARCH AND TREATMENT

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis

(2016) Xuan-Anh Phi et al.   BRITISH JOURNAL OF CANCER

Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients

(2015) Ulrich Bick   Breast Care

Breast MRI: EUSOBI recommendations for women’s information

(2015) Ritse M. Mann et al.   EUROPEAN RADIOLOGY

Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density

(2015) Christopher C. Riedl et al.   JOURNAL OF CLINICAL ONCOLOGY

Magnetic Resonance Imaging Improves Breast Screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-Analysis

(2015) Xuan-Anh Phi et al.   JOURNAL OF CLINICAL ONCOLOGY

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

(2014) Inge-Marie Obdeijn et al.   BREAST CANCER RESEARCH AND TREATMENT

Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer

(2013) Ellen Warner et al.   ANNALS OF INTERNAL MEDICINE

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

(2013) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis

(2013) B. A. M. Heemskerk-Gerritsen et al.   ANNALS OF ONCOLOGY

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations

(2012) K Passaperuma et al.   BRITISH JOURNAL OF CANCER

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

(2012) E. A. M. Heijnsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening Study

(2011) Ellen Warner et al.   Breast Journal

Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study)

(2010) Francesco Sardanelli et al.   INVESTIGATIVE RADIOLOGY

BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study

(2010) Adriana J. Rijnsburger et al.   JOURNAL OF CLINICAL ONCOLOGY

Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study

(2010)   LANCET ONCOLOGY